BioCentury
ARTICLE | Tools & Techniques

COVID-19 crisis brings CRISPR-Cas13 research into the spotlight

BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.

March 20, 2020 8:39 PM UTC
Updated on Mar 25, 2020 at 10:37 PM UTC

It makes sense that CRISPR-Cas13 would enter the limelight during the COVID-19 crisis, given that the SARS-CoV-2 is an RNA virus, and this Cas enzyme targets RNA.

With diagnostics one of the most critical components of this outbreak, the CRISPR-based diagnostic system could offer a new dimension to the suite of tools that are too-slowly coming into play, at least in the U.S...